HCR Wealth Advisors acquired a new position in shares of cbdMD, Inc. (NYSEAMERICAN:YCBD) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 20,000 shares of the company’s stock, valued at approximately $38,000.

Other large investors also recently modified their holdings of the company. Davy Global Fund Management Ltd increased its holdings in shares of cbdMD by 49.5% in the 2nd quarter. Davy Global Fund Management Ltd now owns 16,380 shares of the company’s stock valued at $31,000 after acquiring an additional 5,421 shares during the period. JPMorgan Chase & Co. increased its holdings in shares of cbdMD by 1,663.4% in the 1st quarter. JPMorgan Chase & Co. now owns 59,496 shares of the company’s stock valued at $55,000 after acquiring an additional 56,122 shares during the period. Bank of New York Mellon Corp increased its holdings in shares of cbdMD by 173.0% in the 1st quarter. Bank of New York Mellon Corp now owns 68,348 shares of the company’s stock valued at $64,000 after acquiring an additional 43,310 shares during the period. Deutsche Bank AG increased its holdings in shares of cbdMD by 2,722.3% in the 1st quarter. Deutsche Bank AG now owns 96,580 shares of the company’s stock valued at $89,000 after acquiring an additional 93,158 shares during the period. Finally, Russell Investments Group Ltd. acquired a new position in shares of cbdMD in the 1st quarter valued at $277,000.

Several equities analysts have issued reports on YCBD shares. TheStreet raised shares of cbdMD from a “d” rating to a “c-” rating in a research note on Wednesday. Zacks Investment Research raised shares of cbdMD from a “hold” rating to a “buy” rating and set a $1.00 price objective on the stock in a research note on Sunday, May 10th. Finally, Cantor Fitzgerald boosted their price objective on shares of cbdMD from $1.20 to $1.80 and gave the company a “neutral” rating in a research note on Monday, May 18th.

Shares of cbdMD stock traded up $0.06 on Friday, hitting $3.30. The company’s stock had a trading volume of 1,162,643 shares, compared to its average volume of 1,441,040. cbdMD, Inc. has a 52-week low of $0.50 and a 52-week high of $5.35.

cbdMD (NYSEAMERICAN:YCBD) last released its quarterly earnings data on Monday, May 18th. The company reported $0.42 EPS for the quarter, topping the consensus estimate of ($0.06) by $0.48. The business had revenue of $9.40 million during the quarter.

cbdMD Profile

cbdMD, Inc produces and distributes various cannibidiol (CBD) products in the United States. It operates through three segments: Products, Licensing, and Entertainment. The Products segment produces and markets CBD tinctures, capsules, gummies, bath bombs, vape oils, topical creams, and animal treats and oils under the cdbMD brand.

Read More: How do buyers and sellers choose a strike price?

Institutional Ownership by Quarter for cbdMD (NYSEAMERICAN:YCBD)

Receive News & Ratings for cbdMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for cbdMD and related companies with MarketBeat.com's FREE daily email newsletter.